SEC Form 4 · accession 0001070081-18-000031
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 5, 2018 | S | 621 | $18.03 | D | 17,154 | D | |
| Common Stock | Jan 5, 2018 | S | 82 | $18.03 | D | 5,125 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares.
- F2Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017.
- F3Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 188 RSUs from a January 4, 2016 grant of 750 shares.